Scan-Associated Distress in People Affected by Cancer: A Qualitative Systematic Review

Hussain, M.; Chau, S.; Turner, M.; Paterson, C.

doi:10.1016/j.soncn.2023.151502

Seminars in Oncology Nursing

2023

DOI: 10.1016/j.soncn.2023.151502

|View full text |Cite

Scan-Associated Distress in People Affected by Cancer: A Qualitative Systematic Review

M. Hussain,

S. Chau,

M. Turner

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements

Mouhanna,

Ståhlberg,

Andersson

et al. 2024

Intl Journal of Cancer

View full text Add to dashboard Cite

Circulating tumour DNA (ctDNA) is an emerging biomarker for monitoring cancers. The personalised disease monitoring in metastatic breast cancer (PDM‐MBC) study is an ongoing study instigated to evaluate ctDNA as a biomarker to individualise imaging requirements in patients with MBC. Patients receiving first‐line endocrine therapy (aromatase inhibitor + cyclin‐dependent kinase 4/6 inhibitor) had plasma samples collected pre‐treatment, weeks 2 and 4, and concurrently with imaging until progressive disease (PD). Here, we apply an experimental analytical workflow for ultrasensitive ctDNA analysis, utilising personalised ctDNA panels designed from mutations identified in tumour tissue, and present results for 24 patients. Twenty patients (83%) had detectable ctDNA pre‐treatment. The median progression‐free survival was 25.6 months, and 13 patients experienced PD, with rising ctDNA detected at or prior to PD in 12 patients (92%). If imaging had been omitted until the detection of rising ctDNA for at least one mutation, 68% (n = 71) of the scans performed amongst ctDNA‐positive patients would have been avoided. Our results demonstrate that integration of personalised ctDNA monitoring of patients with MBC has potential to substantially reduce the imaging needs in patients showing ctDNA response to treatment.

show abstract

Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements

Mouhanna,

Ståhlberg,

Andersson

et al. 2024

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

Beyond the Machine: A Radiographer's Tale

Chau

2025

Journal of Medical Imaging and Radiation Sciences

View full text Add to dashboard Cite

Patient Experiences of Patient–Clinician Communication Among Cancer Multidisciplinary Healthcare Professionals During “Breaking Bad News”: A Qualitative Systematic Review

Primeau,

Chau,

Turner

et al. 2024

Seminars in Oncology Nursing

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Scan-Associated Distress in People Affected by Cancer: A Qualitative Systematic Review

Cited by 3 publications

References 28 publications

Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements

Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements

Beyond the Machine: A Radiographer's Tale

Patient Experiences of Patient–Clinician Communication Among Cancer Multidisciplinary Healthcare Professionals During “Breaking Bad News”: A Qualitative Systematic Review

Contact Info

Product

Resources

About